Leukemia researchHumansLeukemiaMyeloidAcuteBone Marrow
The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysis.
Yuanli Lei, Zhiting Tang, Jessica A Reese, Omer Jamy, Mohamad Khawandanah, Manu Pandey, Muhammad Faisal, Adam Asch, Zimu Gong
Published: 202510.1016/j.leukres.2025.108121
Abstract
BACKGROUND: The current standard of care for acute myeloid leukemia (AML) patients undergoing intensive induction chemotherapy includes an interim bone marrow biopsy around day 14 (D14BM), and reinduction for patients with more than 5 % residual blas…
Preview only. Read the full abstract at the source